100 results
Page 2 of 5
8-K
EX-99.1
a9bwqwttcpj g8
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
8-K
EX-99.1
e08lq y330wyislj4o
30 Oct 23
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
8:15am
424B3
vnv6qpcfl23vjl72
6 Oct 23
Prospectus supplement
1:08pm
424B3
gwbv9z dscjgz3
6 Oct 23
Prospectus supplement
1:06pm
424B3
925iz 0nkd
6 Oct 23
Prospectus supplement
1:04pm
424B3
hm2px03irdnbp2z0d
6 Oct 23
Prospectus supplement
12:59pm
8-K
EX-99.1
65m7iq n17
3 Oct 23
Company to finalize labeling with FDA Approvable Letter expected within a month
4:07pm
8-K
EX-9.1
14qzd8 bw225qfx425lf
24 Aug 23
Regulation FD Disclosure
5:15pm
8-K
EX-99.1
h48mx s15g1z
14 Aug 23
SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update
6:46pm
424B7
6j5q5754fr 7e65
10 Aug 23
Prospectus with selling stockholder info
4:00pm
424B3
kps9y73r2p8r ks94
23 May 23
Prospectus supplement
5:29pm
424B3
ffo tw65aribl038
23 May 23
Prospectus supplement
5:24pm
424B3
a6pm16
23 May 23
Prospectus supplement
5:20pm
DEF 14A
t9zcujg
19 May 23
Definitive proxy
12:06pm
8-K
EX-99.1
jbgjb7 34rxj
16 May 23
SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update
4:06pm
424B3
e2pko
10 May 23
Prospectus supplement
5:19pm
424B3
oaquv
10 May 23
Prospectus supplement
5:17pm
424B3
yzuvnczw2fcg wl
10 May 23
Prospectus supplement
5:15pm